The purpose of this national diagnosis and treatment protocol (PNDS) is to outline to health providers the optimum management and integrated care pathway for patients with long-term conditions (ALD), particularly with status ALD 11: xeroderma pigmentosum (XP).
See also
HAS opinions and decisions
17/06/2009
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
XGPB4hQ2mDLYVzjg
Listen
